Sierra Bancorp reports record Q3 2026 net income of $15.3 million, up 58%, with EPS of $1.18 beating estimates and net ...

Regeneron expands its BARDA agreement by $270 million to supply Inmazeb through 2031 while advancing maftivimab into a ...

Alliance Resource reports Q3 2026 revenue of $603 million, net income of $139.6 million and adjusted EBITDA of $233.9 million ...

City Holding reports record Q3 2026 EPS of $2.43 and $34.6 million in net income as net interest margin rises to 4.04% and ...

Acumen reports a $25.4 million Q3 loss and $78.6 million in cash as it prepares to release Phase 2 sabirnetug Alzheimer's ...

HBT Financial reports Q3 2026 net income of $31.4 million, EPS of $0.86 and a 4.35% net interest margin, ahead of its planned ...

Ovintiv agrees to acquire Logan Energy for about $890 million, adding 266,000 net acres and targeting $60 million in annual ...

Vertiv completes its acquisition of King Environmental Services, expanding liquid cooling, fluid management and data center testing services ...

Enanta doses the first patient in its Phase 2b/3 RESOLVE RSV trial of zelicapavir in high-risk adults, with initial topline ...

Easterly reports Q3 2026 net income of $5.7 million and Core FFO of $38 million, with a 98% leased portfolio and a $0.45 ...

Amanat and Corxel plan a $377 million business combination to fund CX11 Phase 3 obesity trials, targeting a closing in the ...

Phathom says the FDA opened a public docket on VOQUEZNA's exclusivity through 2032, with comments due November 23 amid ...